Population pharmacokinetic analysis of lopinavir in HIV negative individuals exposed to SARS-CoV-2: a COPEP (COronavirus Post-Exposure Prophylaxis) sub-study

Lopinavir/ritonavir (LPV/r) is a drug traditionally used for the treatment of HIV that has been repurposed as a potential post-exposure prophylaxis agent against COVID-19 in the COronavirus Post-Exposure Proph...

Source: BMC Clinical Pharmacology - September 27, 2023 Category: Drugs & Pharmacology Authors: Paul Thoueille, Margot Delfraysse, Pascal Andre, Thierry Buclin, Laurent A. Decosterd, Chiara Fedeli, Pilar Ustero, Alexandra Calmy and Monia Guidi Tags: Research Source Type: research